Literature DB >> 9525583

A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences.

H Chong1, W Starkey, R G Vile.   

Abstract

Previously we reported the presence of a replication-competent retrovirus in supernatant from a vector-producing line derived from a widely used split-function amphotropic packaging cell line. Rigorous routine screening of all retroviral stocks produced in our laboratory has not, previously or since, indicated the presence of such a virus. Replication-competent retroviruses have never previously been used in our laboratory, and stringent screening of all routinely used cell lines has not revealed the presence of any helper viruses. Therefore, it is highly unlikely that this virus represents an adventitious cross-contaminant or had been imported unknowingly with our cell line stocks. PCR studies with DNA from infected cell lines and Northern blot analysis and reverse transcriptase PCR with RNA from infected cells suggest that the helper virus arose by recombination events, at sites of partial homology, between sequences in the vector, one of the packaging constructs, and endogenous retroviral elements. These recombinations were not present in stocks of the packaging cell line or in an initial stock of the vector-producing line, indicating that these events occurred while the vector-producing line was being passaged for harvest of supernatant stocks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525583      PMCID: PMC109708     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes.

Authors:  Y Takahara; K Hamada; D E Housman
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 2.  Retroviral vectors.

Authors:  A D Miller
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  Retroviral recombination and reverse transcription.

Authors:  W S Hu; H M Temin
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

4.  Construction and use of a safe and efficient amphotropic packaging cell line.

Authors:  D Markowitz; S Goff; A Bank
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

5.  Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication.

Authors:  J Zhang; H M Temin
Journal:  Science       Date:  1993-01-08       Impact factor: 47.728

6.  Human cells infected with retrovirus vectors acquire an endogenous murine provirus.

Authors:  D T Scadden; B Fuller; J M Cunningham
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Virological events leading to spontaneous AKR thymomas.

Authors:  J P Stoye; C Moroni; J M Coffin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Analysis of variability among endogenous ecotropic MuLV loci in laboratory mice.

Authors:  P Nouvel; H Philippe; H Condamine; J J Panthier
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

Review 9.  Safety issues related to retroviral-mediated gene transfer in humans.

Authors:  K Cornetta; R A Morgan; W F Anderson
Journal:  Hum Gene Ther       Date:  1991       Impact factor: 5.695

10.  Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.

Authors:  R E Donahue; S W Kessler; D Bodine; K McDonagh; C Dunbar; S Goodman; B Agricola; E Byrne; M Raffeld; R Moen
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  15 in total

1.  Replication-competent lentivirus analysis of clinical grade vector products.

Authors:  Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A Couture; Troy Hawkins; Lisa Duffy
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

2.  Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.

Authors:  Kenneth Cornetta; Lisa Duffy; Cameron J Turtle; Michael Jensen; Stephen Forman; Gwendolyn Binder-Scholl; Terry Fry; Anne Chew; David G Maloney; Carl H June
Journal:  Mol Ther       Date:  2017-09-12       Impact factor: 11.454

3.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

4.  Two-helper RNA system for production of recombinant Semliki forest virus particles.

Authors:  C Smerdou; P Liljeström
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Abrogated cryptic activation of lentiviral transfer vectors.

Authors:  Ralf M Luche; Joerg Enssle; Hans-Peter Kiem
Journal:  Sci Rep       Date:  2012-06-01       Impact factor: 4.379

6.  A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.

Authors:  A L Aloia; L Duffy; V Pak; K E Lee; S Sanchez-Martinez; D Derse; G Heidecker; K Cornetta; A Rein
Journal:  Gene Ther       Date:  2012-03-08       Impact factor: 5.250

7.  Retroviral Vector Biosafety: Lessons from Sheep.

Authors:  Anne Van den Broeke; Arsène Burny
Journal:  J Biomed Biotechnol       Date:  2003

8.  Cross-packaging of genetically distinct mouse and primate retroviral RNAs.

Authors:  Noura Salem Al Dhaheri; Pretty Susan Phillip; Akela Ghazawi; Jahabar Ali; Elizabeth Beebi; Soumeya Ali Jaballah; Tahir A Rizvi
Journal:  Retrovirology       Date:  2009-07-14       Impact factor: 4.602

9.  Design of a trans protease lentiviral packaging system that produces high titer virus.

Authors:  Karen A Westerman; Zhujun Ao; Eric A Cohen; Philippe Leboulch
Journal:  Retrovirology       Date:  2007-12-28       Impact factor: 4.602

10.  The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.

Authors:  Donald S Anson
Journal:  Genet Vaccines Ther       Date:  2004-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.